Entresto 49 mg (Sacubitril (Sacubitril Valsartan Sodium Hydrate Complex) TABLET) 49 MG

ENTRESTO 49 MG tablets contain sacubitril/valsartan, a combination used to manage heart failure. This medication supports heart function and may reduce hospitalization risks. Learn more about its uses and effects.

Strength

49 MG

Pack Size

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ENTRESTO 49 MG tablets are primarily used to treat heart failure, helping to improve heart function and reduce the risk of hospitalization. This medication works by relaxing blood vessels and reducing the workload on the heart. It is often prescribed for individuals with chronic heart failure to enhance their quality of life.

Side Effects

Common effects of ENTRESTO 49 MG tablets may include dizziness, low blood pressure, and cough. Some users might experience fatigue or kidney problems. These effects vary and are not experienced by everyone. Always consult a healthcare provider for personalized advice.

Precautions & Warnings

ENTRESTO 49 MG tablets should be handled with care. Store them at room temperature, away from moisture and heat. Do not crush or chew the tablets. Follow the prescribed dosage and inform your healthcare provider about any other medications you are taking.

Avoid Interactions

ENTRESTO 49 MG tablets may interact with other medications, including ACE inhibitors, ARBs, and NSAIDs. Alcohol consumption should be limited, as it can enhance the blood pressure-lowering effects. Always consult a healthcare provider before starting or stopping any medication.

Frequently Asked Questions

ENTRESTO 49 MG tablets are used to manage heart failure and improve heart function.

ENTRESTO 49 MG tablets should be taken orally, usually once or twice daily, as prescribed by a healthcare provider.

Common side effects may include dizziness, low blood pressure, and cough. Always consult a healthcare provider for personalized advice.

Alcohol consumption should be limited, as it can enhance the blood pressure-lowering effects of ENTRESTO 49 MG.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.